[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SV2007002315A - DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL REF. PC32623A - Google Patents

DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL REF. PC32623A

Info

Publication number
SV2007002315A
SV2007002315A SV2005002315A SV2005002315A SV2007002315A SV 2007002315 A SV2007002315 A SV 2007002315A SV 2005002315 A SV2005002315 A SV 2005002315A SV 2005002315 A SV2005002315 A SV 2005002315A SV 2007002315 A SV2007002315 A SV 2007002315A
Authority
SV
El Salvador
Prior art keywords
pirrol
derivatives
pc32623a
octahidropirrolo
ref
Prior art date
Application number
SV2005002315A
Other languages
Spanish (es)
Inventor
Charlotte Alice Louise Lane
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35985757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2007002315(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04106044A external-priority patent/EP1671972A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of SV2007002315A publication Critical patent/SV2007002315A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A DERIVADOS DE OCTAHIDROPIRROLO [3,4-C] PIRROL DE FORMULA (VER FORMULA) Y A PROCEDIMIENTOS PARA SU PREPARACION, A COMPOSICIONES QUE LOS CONTIENEN Y A SUS USOSREFERS TO OCTAHYDROPIRROLO DERIVATIVES [3,4-C] FORMULA PIRROL (SEE FORMULA) AND PROCEDURES FOR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USES

SV2005002315A 2004-11-24 2005-11-24 DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL REF. PC32623A SV2007002315A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106044A EP1671972A1 (en) 2004-11-24 2004-11-24 Octahydropyrrolo[3,4-c]pyrrole derivatives
EP05100474 2005-01-26

Publications (1)

Publication Number Publication Date
SV2007002315A true SV2007002315A (en) 2007-02-16

Family

ID=35985757

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002315A SV2007002315A (en) 2004-11-24 2005-11-24 DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL REF. PC32623A

Country Status (12)

Country Link
EP (1) EP1846409A1 (en)
JP (1) JP2008520644A (en)
AR (1) AR054707A1 (en)
CA (1) CA2587141A1 (en)
GT (1) GT200500340A (en)
NL (1) NL1030503C2 (en)
PA (1) PA8653801A1 (en)
PE (1) PE20061055A1 (en)
SV (1) SV2007002315A (en)
TW (1) TW200626600A (en)
UY (1) UY29221A1 (en)
WO (1) WO2006056848A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079694B1 (en) 2006-12-28 2017-03-01 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
JPWO2011013752A1 (en) * 2009-07-31 2013-01-10 塩野義製薬株式会社 Pharmaceutical composition containing a fused heterocyclic derivative
JP5847087B2 (en) 2009-10-23 2016-01-20 ヤンセン ファーマシューティカ エヌ．ベー． Fused heterocyclic compounds as orexin receptor modulators
WO2011050202A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
RS59004B1 (en) 2009-10-23 2019-08-30 Janssen Pharmaceutica Nv Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
HUE039713T2 (en) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitors for treating tinnitus
CN115154470B (en) 2016-03-10 2024-09-20 詹森药业有限公司 Methods of treating depression using orexin-2 receptor antagonists
WO2019152883A1 (en) * 2018-02-02 2019-08-08 Padforward Llc Inhibitors of protein arginine deiminases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2620341A (en) * 1949-03-24 1952-12-02 Burroughs Wellcome Co N,n-dialkyl-quinoline-4-carboxamidines
CN1068328C (en) * 1995-05-11 2001-07-11 法玛西雅厄普约翰美国公司 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
MXPA03008143A (en) * 2001-03-09 2005-08-16 Johnson & Johnson Heterocyclic compounds.
DK1543011T3 (en) * 2002-09-06 2006-08-07 Janssen Pharmaceutica Nv Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine H4 receptor ligands
RU2005106274A (en) * 2002-09-06 2005-11-10 Янссен Фармацевтика, Н.В. (Be) HETEROCYCLIC COMPOUNDS
AU2003265961A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma

Also Published As

Publication number Publication date
JP2008520644A (en) 2008-06-19
UY29221A1 (en) 2006-06-30
CA2587141A1 (en) 2006-06-01
TW200626600A (en) 2006-08-01
EP1846409A1 (en) 2007-10-24
NL1030503C2 (en) 2006-11-28
WO2006056848A1 (en) 2006-06-01
PA8653801A1 (en) 2006-06-02
NL1030503A1 (en) 2006-05-29
AR054707A1 (en) 2007-07-11
GT200500340A (en) 2006-07-13
PE20061055A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
HN1999000106A (en) HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS.
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
CU20090072A7 (en) L-GLUTAMIC ACID MARKED WITH [F-18], L-GLUTAMINE MARKED WITH [F-18], ITS DERIVATIVES AND ITS USE, AS WELL AS PROCEDURES FOR PREPARATION
ECSP066541A (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
UY29795A1 (en) ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
SV1999000118A (en) NEW SUBSTITUTED PIRAZOL DERIVATIVES REF. READ 33188-SV
AR057325A1 (en) SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES
UY30681A1 (en) PIRIDINAMIDE COMPOUNDS CONTAINING CARBOXI, PHARMACEUTICALLY ACCEPTABLE SALTS, PROCEDURES FOR THE PREPARATION OF THE SAME, COMPOSITIONS THAT CONTAIN THEM AND THEIR USES.
CR10149A (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES AND THERAPEUTIC USE
UY29893A1 (en) PIRAZINE DERIVATIVES
HN2003000064A (en) USEFUL NICOTINAMIDE DERIVATIVES AS PDE4 INHIBITORS
HN2003000062A (en) USEFUL NICOTINAMIDE DERIVATIVES AS PDE4 INHIBITORS
UY29002A1 (en) NEW HIDANTOINE DERIVATIVES, PARASU PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY
UY30195A1 (en) DERIVATIVES OF PHENETANOLAMINE, PREPARATION PROCEDURE, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
CR8205A (en) USEFUL NICOTINAMIDE DERIVATIVES AS PDE4 INHIBITORS
CU23415B7 (en) DERIVATIVES OF 2,6- QUINOLINILO AND 2,6- NAFTILO, PROCESSES FOR THEIR PREPARATION AND ITS USES
HN2008001393A (en) DERIVATIVES OF 1,2,4,5- TETRAHIDRO -3H- BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY30610A1 (en) MGLUR5 MODULATORS
UY29818A1 (en) NEW AZETIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND THERAPEUTIC USES
PA8577201A1 (en) 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMID AND DERIVATIVES 3-PHENYL-PROPINAMID AS MAO-B INHIBITORS
UY31905A (en) DERIVATIVES OF BENZOXAZINONA, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS.
UY29892A1 (en) NEW CHROMAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
CR9391A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SV2007002315A (en) DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL REF. PC32623A
DOP2010000155A (en) PIRAZOL DERIVATIVES AS 5-LO INHIBITORS

Legal Events

Date Code Title Description
FD Lapse